TOP TIERMARKET NEWSWIRE
News & sentiment

VANDA PHARMACEUTICAL (VNDA) — News & AI sentiment

VANDA PHARMACEUTICAL (VNDA) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 57/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 57/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

VNDA news in the last 24 hours, 7 days, 30 days and 90 days

How much VNDA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowVNDA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days557/100VNDA headlines →
Last 90 days2455.2/100VNDA headlines →

Latest stories on VNDA

Sep 2
Aug 24
Aug 24
Aug 22
Aug 22
Vanda (VNDA) Q2 2026 Earnings Call Transcript
Yahoo Top63 · neutralearnings
Aug 12
Vanda (VNDA) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Aug 12
Aug 10
H.C. Wainwright cuts Vanda Pharmaceuticals price target to $20
Investing.com Analyst Ratings34 · bearishanalyst
Aug 10
Aug 10
Aug 6
Aug 6
Aug 5
Aug 5
Jul 29
Jul 17
Jul 16
Jul 16
Jul 10
Jul 10
Jul 8
Jul 7
Jul 7
Jul 3
Jun 5
Open VNDA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →